Q3 2016 Holdings
Filed 2016-11-14 | 84 holdings | $106.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $26.8M | 2,071,964 | 25.2% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $23.1M | 901,286 | 21.7% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $15.4M | 576,106 | 14.5% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $12.0M | 498,117 | 11.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $8.8M | 455,515 | 8.3% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.5M | 126,120 | 8.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.8M | 371,636 | 5.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.5M | 214,132 | 3.3% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.3M | 62,254 | 1.2% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $178.0K | 25,307 | 0.2% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $55.4K | 1,689,071 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $51.3K | 491,044 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $40.5K | 1,118,372 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $39.5K | 2,800,000 | 0.0% |
| Proteostasis Therapeutics in | COM | 74373B109 | $36.6K | 2,350,000 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $34.5K | 1,988,208 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $31.9K | 455,995 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $30.5K | 1,771,263 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $26.2K | 1,605,790 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $23.4K | 650,000 | 0.0% |
| Quotient LTD | SHS | G73268107 | $21.8K | 2,787,717 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $21.4K | 334,044 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $21.2K | 707,978 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.2K | 398,301 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $18.9K | 1,695,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $16.9K | 800,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $16.5K | 507,907 | 0.0% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $16.4K | 2,121,013 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $14.1K | 112,867 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $13.6K | 2,000,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $13.5K | 596,000 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $11.3K | 1,578,106 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $10.5K | 767,466 | 0.0% |
| Advaxis Inc | COM NEW | 007624208 | $9.8K | 920,915 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $9.8K | 900,000 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $9.5K | 3,840,966 | 0.0% |
| Inc Resh Hldgs Inc | CL A | 45329R109 | $8.9K | 200,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $8.9K | 298,870 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $8.8K | 100,000 | 0.0% |
| Achillion Pharmaceuticals(ACHNEUR) | COM | 00448Q201 | $8.2K | 1,006,128 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $8.0K | 449,660 | 0.0% |
| Emergent Biosolutions Inc(EBS) | COM | 29089Q105 | $7.9K | 250,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.9K | 110,842 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $7.8K | 1,150,000 | 0.0% |
| Fulgent Genetics Inc(FLGT) | COM | 359664109 | $7.4K | 800,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $7.1K | 339,175 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $6.5K | 1,402,331 | 0.0% |
| Curis Inc | COM | 231269101 | $6.3K | 2,410,900 | 0.0% |
| Zynerba Pharmaceuticals Inc | COM | 98986X109 | $6.3K | 480,501 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $5.9K | 669,239 | 0.0% |